Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors

被引：6

作者：

Lucas, Matthew C. ^{[1
]}

Carter, David S. ^{[1
]}

Cai, Hai-Ying ^{[1
]}

Lee, Eun Kyung ^{[1
]}

Schoenfeld, Ryan C. ^{[1
]}

Steiner, Sandra ^{[1
]}

Villa, Marzia ^{[1
]}

Weikert, Robert J. ^{[1
]}

Iyer, Pravin S. ^{[1
]}

机构：

[1] Roche Palo Alto LLC, Palo Alto, CA 94304 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 16期

关键词：

TRI; Triple reuptake inhibitor; Monoamine reuptake inhibitor; Neurotransmitter; Indole; Major depressive disorder; DEPRESSION;

D O I：

10.1016/j.bmcl.2009.06.076

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A variety of novel aminoheterocycle scaffolds as selective monoamine reuptake inhibitors have been prepared and one of these scaffolds is achiral. The main elements responsible for hERG channel, CYP2D6 and CYP3A4 inhibition were identified. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：4630 / 4633

页数：4

共 12 条

[1] Baldessarini RJ, 2001, PHARM BASIS THERAPEU, V10th, P451
[2] Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]
[3] CARTER DS, 2008, Patent No. 2008019971
[4] Depressive illness
Doris, A
Ebmeier, K
Shajahan, P
[J]. LANCET, 1999, 354 (9187) : 1369 - 1375
[5] In vitro metabolic fate of a novel structural class: Evidence for the formation of a reactive intermediate on a benzothiophene moiety
Evans, CA
Fries, HE
Ward, KW
[J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2005, 152 (01) : 25 - 36
[6] GREENHOUSE R, 2007, Patent No. 2007123535
[7] Greenhouse R., 2005, [No title captured], Patent No. [WO 2005118539, 2005118539]
[8] Iyer P., 2007, U.S. Pat. Appl. Publ., Patent No. [US 20070123527 Al 20070531, 20070123527]
[9] Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease
Lemke, Matthias R.
Brecht, H. Michael
Koester, Juergen
Reichmann, Heinz
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 266 - 270
[10] Psychopathology of depression
Leonard, Brian E.
[J]. DRUGS OF TODAY, 2007, 43 (10) : 705 - 716

← 1 2 →